))
SS24 E02 Report Back From ASCO 2024: What’s the Latest in HR+ MBC?
Manage episode 431638876 series 2977267
Inhoud geleverd door SHARE Cancer Support. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door SHARE Cancer Support of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Today, we’re bringing you a very special episode created in partnership with SHARE Cancer Support. This is an audio version of our Webinar Report Back from ASCO 2024: Latest Updates on Metastatic Breast Cancer (MBC).
We're excited to present this report from the 2024 ASCO Annual Meeting, highlighting the latest advancements and research in hormone receptor positive (HR+) metastatic breast cancer.
In today's episode, you will hear from Dr. Kevin Kalinsky, a medical oncologist and investigator from Emory. We will dive deep into the findings from the DESTINY-Breast06 trial and the postMONARCH trial. We'll explore the implications of these studies, how they could impact treatment strategies, and what this means for us.
155 afleveringen
Delen
